Mutual of Omaha Bank Wealth Management Trims Stake in Clorox Co (CLX)

Mutual of Omaha Bank Wealth Management cut its holdings in Clorox Co (NYSE:CLX) by 22.0% during the third quarter, Holdings Channel reports. The institutional investor owned 1,600 shares of the company’s stock after selling 450 shares during the period. Mutual of Omaha Bank Wealth Management’s holdings in Clorox were worth $241,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. Exeter Financial LLC boosted its position in Clorox by 3.9% in the 2nd quarter. Exeter Financial LLC now owns 9,719 shares of the company’s stock valued at $1,314,000 after buying an additional 367 shares during the period. Oppenheimer Asset Management Inc. boosted its position in Clorox by 1.6% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 23,638 shares of the company’s stock valued at $3,197,000 after buying an additional 383 shares during the period. Global X Management Co LLC boosted its position in Clorox by 6.0% in the 2nd quarter. Global X Management Co LLC now owns 6,899 shares of the company’s stock valued at $933,000 after buying an additional 391 shares during the period. Spearhead Capital Advisors LLC boosted its position in Clorox by 1.6% in the 3rd quarter. Spearhead Capital Advisors LLC now owns 25,798 shares of the company’s stock valued at $3,867,000 after buying an additional 403 shares during the period. Finally, Advisor Partners LLC boosted its position in Clorox by 10.8% in the 2nd quarter. Advisor Partners LLC now owns 4,172 shares of the company’s stock valued at $564,000 after buying an additional 408 shares during the period. Hedge funds and other institutional investors own 78.38% of the company’s stock.

Shares of CLX opened at $149.76 on Tuesday. Clorox Co has a fifty-two week low of $113.57 and a fifty-two week high of $155.23. The company has a market capitalization of $18.88 billion, a PE ratio of 23.92, a price-to-earnings-growth ratio of 3.53 and a beta of 0.36. The company has a debt-to-equity ratio of 3.15, a current ratio of 1.09 and a quick ratio of 0.67.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Thursday, August 2nd. The company reported $1.66 earnings per share for the quarter, topping the consensus estimate of $1.58 by $0.08. Clorox had a net margin of 13.44% and a return on equity of 103.18%. The firm had revenue of $1.69 billion during the quarter, compared to analysts’ expectations of $1.72 billion. During the same quarter in the prior year, the company earned $1.53 EPS. The company’s revenue was up 2.7% compared to the same quarter last year. As a group, equities analysts expect that Clorox Co will post 6.41 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 16th. Stockholders of record on Wednesday, October 31st will be given a $0.96 dividend. The ex-dividend date of this dividend is Tuesday, October 30th. This represents a $3.84 annualized dividend and a dividend yield of 2.56%. Clorox’s payout ratio is presently 61.34%.

Several equities research analysts have issued reports on the stock. UBS Group assumed coverage on shares of Clorox in a research report on Wednesday, July 18th. They issued a “sell” rating and a $110.00 price objective for the company. BMO Capital Markets reissued a “buy” rating and issued a $153.00 price objective on shares of Clorox in a research report on Friday, August 3rd. ValuEngine raised shares of Clorox from a “hold” rating to a “buy” rating in a research report on Saturday, September 22nd. Zacks Investment Research raised shares of Clorox from a “hold” rating to a “buy” rating and set a $171.00 price objective for the company in a research report on Wednesday, October 3rd. Finally, Wells Fargo & Co boosted their price objective on shares of Clorox from $135.00 to $145.00 and gave the company a “market perform” rating in a research report on Wednesday, October 17th. Four investment analysts have rated the stock with a sell rating, eight have given a hold rating and four have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $138.29.

In related news, EVP Linda J. Rendle sold 382 shares of the business’s stock in a transaction that occurred on Thursday, September 6th. The shares were sold at an average price of $148.32, for a total transaction of $56,658.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Dawn C. Willoughby sold 3,387 shares of the business’s stock in a transaction that occurred on Wednesday, September 5th. The stock was sold at an average price of $148.01, for a total transaction of $501,309.87. The disclosure for this sale can be found here. Insiders sold a total of 29,268 shares of company stock valued at $4,196,686 in the last ninety days. Corporate insiders own 1.40% of the company’s stock.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Featured Article: Bull Market

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply